Frazier Life Sciences VIII L.P. 13D and 13G filings for Alpine Immune Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-21 10:21 am Sale |
2024-05-20 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 0 0.000% |
-6,090,980 (Position Closed) |
Filing |
| 2024-04-29 6:08 pm Purchase |
2024-04-25 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 6,090,980 9.300% |
8,079 (+0.13%) |
Filing |
| 2023-11-22 10:25 am Purchase |
2023-11-20 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 6,082,901 9.800% |
2,918,793 (+92.25%) |
Filing |
| 2022-02-15 2:18 pm Sale |
2022-02-11 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 3,164,108 10.800% |
-13,734 (-0.43%) |
Filing |
| 2021-09-21 3:37 pm Purchase |
2021-09-17 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 3,177,842 10.000% |
440,741 (+16.10%) |
Filing |
| 2020-07-30 8:16 pm Purchase |
2020-07-28 | 13D | Alpine Immune Sciences, Inc. ALPN |
Frazier Life Sciences VIII L.P. | 2,737,101 11.500% |
11,475 (+0.42%) |
Filing |